Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
What do you consider when there is incidentally found patchy peripheral nerve enlargement on imaging with otherwise unremarkable clinical and electrophysiological findings?
e.g. identified via PET scan, CT scan, or ultrasound for other indication
Related Questions
Do you find IVIG to be an effective maintenance therapy for myasthenia gravis?
How do you adjust dosing of rozanolixizumb for MG patients who deteriorate before the minimum re-dosing period?
How do you approach patients with positive LRP4 antibodies without clinical findings of myasthenia gravis?
What is your approach to a child with toe walking with a reassuring exam but a family history of difficulty walking?
When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?
When do you test for myasthenia antibodies beyond AChR and MuSK?
How do you counsel patients with dermatomyositis on sun protection?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
How do you approach sequentially tapering combination therapy (i.e., IVIG, mycophenolate, rituximab) for dermatomyositis that is in remission?
Would you add immunosuppression in ocular myasthenia gravis patients who are symptomatically well-controlled on pyridostigmine?